In a surprise move Thursday, Neumora remade its executive team and brought back its former CEO, following last month's ...

WATERTOWN, Mass. - Neumora Therapeutics , Inc. (NASDAQ:NMRA), a clinical-stage biopharmaceutical company focused on brain disease treatments, announced leadership changes effective February 14, with ...

Paul L. Berns, executive chair of Neumora Board of Directors, to serve as chief executive officer and chairman of the BoardJoshua Pinto, Ph.D. to ...